All In MedTech

Device Trial Radar · NCT06580405

A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia

A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Patients With Preeclampsia With Severe Features

Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

13

Planned (sponsor's estimate)

Start

Oct 1, 2026

Primary completion

Aug 31, 2027

Study completion Nov 30, 2029

Sponsor

Lead sponsor
Kaneka Medical America LLCNot on our public-company list
Sponsor type
Industry
First posted
Aug 30, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will primarily evaluate safety of the KNP-1000 apheresis system for pregnant women and their fetuses diagnosed with preeclampsia with severe features between 23- and 32-weeks' gestation (very preterm).

Conditions

  • Pre-Eclampsia, Severe

Interventions

  • KNP-1000 Apheresis SystemDevice

    sFlt-1 is removed from the participants' plasma through treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Antepartum maternal and fetal device-related serious adverse eventsTime frame: Until date of delivery
  2. Postpartum maternal and neonatal device-related serious adverse eventsTime frame: Following delivery until end of follow-up (2 years)
  3. Maternal, fetal, and neonatal mortalityTime frame: Until end of follow-up (2 years)

4 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.